Abstract
The biologic functions attributed to the nucleophosphoprotein p53 have been increasing in recent years. Some studies suggested that wild type p53 is responsible for cell cycle arrest brought about as a response to exposure of mammalian cells to DNA-damaging agents. This cell cycle arrest occurs in order for cells to repair the damaged macromolecules. Extensively damaged cells are also thought to undergo apoptosis via the p53-dependent or -independent signal transduction pathways. In this study, we investigated the ability of diaziridinylbenzoquinones to increase p53 levels in the human breast cancer cell line MCF-7. Diaziquone (AZQ), an anticancer agent, and its derivatives, diaziridinequinone (DZQ) and methyldiaziridinequinone (MeDZQ), induced p53 in a dose- and time-dependent manner as measured by the electrophoretic mobility shift assay. Wild type p53 induction by AZQ was suppressed when DT-diaphorase activity was inhibited by pretreating the cells with dicumarol. Aside from their potent alkylating activity, these agents also undergo redox cycling as evidenced by oxygen consumption and the production of reactive oxygen species (ROS). Inhibition of ROS production by the antioxidant enzyme catalase reduced AZQ- and DZQ-mediate...Continue Reading
References
Oct 20, 1992·Biochemical Pharmacology·G R FisherP L Gutierrez
Jun 1, 1992·Molecular and Cellular Biology·W D FunkJ W Shay
Jan 1, 1991·Free Radical Biology & Medicine·G R Fisher, P L Gutierrez
Jul 5, 1991·Science·M HollsteinC C Harris
Dec 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·I B RunnebaumS Sukumar
Jun 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·A M DavidoffJ R Marks
Jul 30, 1990·FEBS Letters·Z Y JiangS P Wolff
Aug 1, 1986·Journal of Virology·J W YewdellD P Lane
Jan 1, 1987·Pharmacology & Therapeutics·G Powis
Dec 1, 1985·Journal of Pharmaceutical Sciences·M M MossobaP L Gutierrez
May 1, 1983·Archives of Biochemistry and Biophysics·P L GutiérrezN R Bachur
Feb 1, 1995·Seminars in Cancer Biology·C E Canman, M B Kastan
Jan 27, 1995·Cell·T Miyashita, J C Reed
Mar 1, 1995·The Journal of Cell Biology·G R MerloN E Hynes
Nov 1, 1994·European Journal of Immunology·H SekiT Miyawaki
Feb 1, 1994·The International Journal of Biochemistry·H Selter, M Montenarh
Jan 1, 1993·Molecular Carcinogenesis·K TakahashiT Ono
Sep 2, 1993·Nature·J A Pietenpol, B Vogelstein
Apr 1, 1995·Leukemia & Lymphoma·E W Newcomb
Citations
Jul 13, 2004·Cancer Treatment Reviews·S DansonM Ranson
Oct 18, 2000·Free Radical Biology & Medicine·P L Gutierrez
Oct 12, 2000·Free Radical Biology & Medicine·B LiP L Gutierrez
Dec 3, 2015·Chemical Research in Toxicology·Aurimas StulpinasAudronė Valerija Kalvelytė
Feb 27, 2003·Journal of Neurochemistry·Krisztian J KapinyaHeide Hörtnagl
Feb 28, 2002·Redox Report : Communications in Free Radical Research·P A AmstadP L Gutierrez
Jun 26, 2013·Acta Crystallographica. Section E, Structure Reports Online·V GaumetV P Zaitsev
Feb 23, 2007·Birth Defects Research. Part C, Embryo Today : Reviews·Peter Kovacic, Robert S Pozos
Sep 28, 2020·Medicinal Research Reviews·Junmin ZhangJianguo Fang
Sep 15, 2005·The Journal of Biological Chemistry·Dashnamoorthy RaviKumuda C Das
Jan 15, 2002·Journal of Biomolecular Screening·C R AlbanoG Rao
May 7, 2008·Journal of Medicinal Chemistry·Mary HassaniHoward D Beall